Recalled Epidural Steroid Injection Linked to Meningitis Given to Thousands

Thousands of people throughout the United States may be in danger of contracting a life-threatening strain of fungal meningitis that has already killed eight people and sickened more than 100 people nationwide. 

The U.S. Centers for Disease Control and Prevention (CDC) indicates that as many as 13,000 people may have received potentially contaminated epidural steroid injections from the New England Compounding Center (NECC), which has been linked to a nationwide fungal meningitis outbreak.

The compounding pharmacy recalled more than 17,000 shots and shut down operations once the outbreak of meningitis was linked to its drugs. The CDC has been issuing daily updates on the outbreak.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

A death in Tennessee on Monday raised the death toll of the outbreak to eight. That state has been the hardest hit, with 35 illnesses and four deaths at last count. Other states affected by the outbreak include Florida, Indiana, Maryland, Michigan, Minnesota, North Carolina, Ohio and Virginia.

The CDC based its estimate of potential people affected on the three lots of preservative-free methylprednisolone acetate known to be contaminated. However, New England Compounding Center has recalled all of its injection drugs after the FDA raised concerns that problems at the company may be systemic.

At least two different strains of fungal meningitis have been identified as originating from the compounding pharmacy’s drugs. Not everyone who got a contaminated shot will get sick, the CDC noted.

The recalled epidural steroid injections were shot directly into the spine of patients by hospitals and pain management centers nationwide.

The number of illnesses may rise for some time, since the shots were distributed between May 21, 2012 and were on the market until September 26. It can take up to a month for fungal meningitis to appear in infected persons, meaning illnesses and deaths may continue to pour in through late October.

Fungal meningitis is a type of meningitis that in this case was caused by aspergillius, a common mold that somehow tainted vials of the epidural injections. It causes inflammation of the spinal cord and protective membranes covering the brain. The inflammation generally causes an infection of the fluid surrounding the brain and spinal cord and can also be caused by parasites, viruses and bacterial infection.

Individuals with a weakened immune system may be at a particularly high risk of contracting fungal meningitis.

Symptoms of meningitis following an epidural steroid injection may include fever, headache, stiff neck, nausea, vomiting, increased sensitivity to light and mental confusion. Signs of meningitis usually develop within three to seven days after exposure. As the disease progresses, symptoms may become severe, resulting in seizures, coma and death.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S.
Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S. (Posted 2 days ago)

A recently filed Depo-Provera lawsuit questions why Pfizer updated the drug label in Europe, to warn about the risk of meningioma brain tumors, but failed to provide the same Depo-Provera warnings to U.S. consumers and doctors.

Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week
Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week (Posted 4 days ago)

U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.